People channel feed – Endpoints News

People channel feed

The right to vote is fundamental — a letter from biotechnology industry leaders

5 years ago

Former head of FDA’s medical and scientific affairs on Covid: ‘FDA has never been tested like this’

5 years ago

Pankaj Bhargava was a central figure in the group fashioning Gilead’s oncology strategy. Now he’s jumped to the VC side and the next-gen game at Dana-Farber

5 years ago

Amarin CEO John Thero passes baton to Europe commercial chief as M&A hopes continue to deflate

5 years ago

Patrizia Cavazzoni named permanent director of CDER, adding to questions around where Woodcock will end up

5 years ago

The numbers are in, and new Vertex CEO Reshma Kewalramani took home half of what predecessor Jeff Leiden did in his last year on the job

5 years ago

Can he pick them? A high-profile Wall Street analyst jumps into biotech as CFO of an oncology upstart

5 years ago

The CHIC interview: Stéphane Bancel on Moderna's overnight transformation, the new timeline on vaccine development and his one regret in 2020

5 years ago

Publisher's note

Female entrepreneurs have long been underrepresented in biotech. An MIT team decided to find out why

5 years ago

Amgen CEO Bob Bradway takes home $20M+ pay package amid bang-up year for sales

5 years ago

The Endpoints 100 survey: CEOs changed the way biotechs operate during the pandemic. Things will never be the same again

5 years ago

David Davidson’s R&D odyssey takes him out of bluebird to another biotech startup with big plans to transform therapy

5 years ago

Nearly 70% of Akcea's workforce is on the chopping block as Ionis executes major restructuring

5 years ago

Despite remdesivir approval and 2 big buyouts, Gilead CEO Dan O'Day sees pay fall 35% from 2019

5 years ago

As Covid-19 vaccine was being developed, Moderna shelled out more than $1M for top executives' security

5 years ago

Big Pharma R&D veteran with blockbuster credentials returns to his biotech roots as Prothena's new CMO

5 years ago

Martin Shkreli pushes back on lifetime public company ban from prison cell in bid to get back to business

5 years ago

Alcami appoints new CEO in Patrick Walsh, the executive who helped lead the CDMO's predecessor company

5 years ago

It's time: After 19 years, legendary Koch Institute director Tyler Jacks passes the torch to Matthew Vander Heiden

5 years ago

Biotech pioneer and startup investor John Martin, who built Gilead into a powerhouse player, has died

5 years ago

After leaving Merck's C-suite, Mike Nally turns up at the helm of a Flagship machine learning company

5 years ago

Looking to leave Zolgensma data manipulation scandal behind, Brian Kaspar emerges at a new gene therapy player

5 years ago

Moncef Slaoui resigns from post-GlaxoSmithKline home Medicxi after harassment allegations

5 years ago

Gilead R&D chief William Lee to retire as Amgen I/O vet Flavius Martin takes the reins in April

5 years ago

First page Previous page 58 59 606162 63 64 Next page Last page